What is InnoGen?

InnoGen is the umbrella firm of a group of nine (9) Filipino pharmaceutical companies, with each of them assigned to cover major therapeutic areas.

What does "InnoGen" means?

InnoGen is simply characterized by the catchphrase "Innovating Generics". Our goal is to make a difference in the pharmaceutical industry by improving existing products, into new forms and much better drugs, that are cost-effective, efficient and of excellent quality, for the welfare of the end-users. Hence, our battlecry in the service of the People: "Valuing Life through Innovations".

Who owns InnoGen?

InnoGen is a corporation. It is owned by numerous shareholders who have combined their efforts and resources to build InnoGen with the vision "to become the leader in providing quality healthcare in the Philippines and be a globally-competitive pharmaceutical company that would be known in technological innovations" and with the mission "to develop and provide quality, innovative and affordable pharmaceutical products for the Filipinos".

Dr. Lloyd Balajadia and Mrs. Virginia de Guzman are just a few of the shareholders. Many other Filipino businessmen have invested on InnoGen as well.

Who are the officers of InnoGen?

The corporate group is headed by our Executive Director, Dr. Lloyd Balajadia, Mrs. Virginia De Guzman heads the Finance and the Medical Affairs is headed by our Patient Care Director, Dr. Ma. Helen Grace Florentino.

What are the classes of products InnoGen offers to the market?

InnoGen is continuously exploring, researching, developing and introducing numerous high-profile, second to the originator, first Filipino-made generic, life-saving medicines that ranges from Antibiotics to Anti-hypertensive drugs, to Anti-Obesity and Anti-Diabetes drugs, to Anti-Inflammatory and Pain Management drugs.

Who manufactures InnoGen products?

InnoGen establishes partnerships with leading manufacturers here and abroad. Quality has always been our foremost consideration in choosing the right pharmaceutical partner. Currently, Lloyd Laboratories, Inc., an ISO certified and cGMP (current good manufacturing practices) compliant pharmaceutical manufacturing produces majority of our products.

InnoGen partnered with Lloyd Labs in an effort to expedite the introduction of high-profile life-saving medicines in the country and by offering it at costs unparalleled to the rest of the industry.

Does InnoGen own Lloyd Laboratories?

No. InnoGen does not own Lloyd Labs and Lloyd Labs does not own InnoGen. They are completely separate and independent corporate entity that has established a partnership that will bring about an influx of new products starting 2007.

Where do you source your raw materials?

InnoGen sources its raw materials from internationally accredited and FDA-compliant facilities in Europe and in Asia. One of our major raw materials suppliers is DSM, a Swiss company, which has supplied raw materials to big multinational companies around the world. Our capsules are sourced through Capsugel. The company is a subsidiary of Pfizer.

Do you have Bioequivalence studies?

Yes. Currently we have bioequivalence for AMLODINE (amlodipine besylate), ZIONEL (metoprolol tartrate), GABATIN (gabapentin), METADAY (metformin) and LOSARGARD (losartan), CLOPIVAZ (Clopidogrel), But we will be coming up with more studies with some of our new brands. Although only ZIONEL and Vimetrol is required to have a study, we went a step forward and make AMLODINE, GABATIN and LOSARGARD have their own bioequivalence study, even if it is not required by BFAD.

Note: See Bioequivalence FAQs.

How can I be assured of the quality of your products?

InnoGen had made sure that the products that healthcare professionals give their patients have passed the stringent standards set by the Bureau of Food and Drugs. From raw materials, to production, to packaging, and finally, to the end-users, InnoGen products are assured of high quality, efficacy and safety that are at par with the originator drugs.

Where can my patient buy InnoGen products?

InnoGen products are sold at reputable chain drugstores that have their own team of evaluators to make sure that all products sold in their outlet are of the highest degree of quality. Mercury Drug, Rose Pharmacy, Negros Grace and Manson Drug are among the reputable outlets that carries InnoGen products.

What is InnoGen's PharmacoVigilance campaign?

Pharmacovigilance is not a new word in the healthcare community, it pertains to the pharmacological science relating to the detection, assessment, understanding and prevention of adverse effects, particularly long term and short term side effect of medicines. But InnoGen had expanded its meaning by adopting it as a way of providing quality healthcare to the Filipinos.

InnoGen's PharmacoVigilance is Innogen's way of ensuring product efficacy and safety; Innogen's way of safeguarding Filipinos health against high priced medicines; and Innogen's way of ensuring availability of innovative and quality products in the Philippines.

How would I benefit with this campaign?

Our doctors and their patients will benefit from this campaign by discovering the different healthcare issues the Filipinos are facing right now and the availability of solutions that InnoGen offers.

The health of Filipinos is compromised by the high cost of medicine. Access to medicines is denied because of several factors that influence the prices of drugs. As a result, health care is lopsided - favoring those who can afford essential medicines and putting the health - and lives - of most Filipinos at risk.

InnoGen, an innovation driven company, provides essential pharmaceutical products that results from the un-ending drive to provide Filipinos with cost-effective medicines that will surely allow them to continue their medication. The innovation InnoGen utilizes does not increase the prices of medicines, in fact, the innovation involves lowers the cost of therapy of selected products in the long run, which is much more significant compared to the products offered by multinational and big local pharmaceutical firms.

Back to top

Copyright © INNOGEN PHARMA GROUP, INC. 2009.   All rights reserved.